NCT07602582 A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). Status NOT_YET_RECRUITING Phase PHASE3
NCT07589595 A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) Status NOT_YET_RECRUITING Phase PHASE2
NCT07571161 Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease Status NOT_YET_RECRUITING Phase PHASE3
NCT06996730 A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06911944 Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation Status NOT_YET_RECRUITING Phase PHASE4
NCT06566170 A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease Status RECRUITING Phase N/A
NCT05738486 A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05533411 A Study of Donanemab (LY3002813) in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT05508789 A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05108922 A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4) Status COMPLETED Phase PHASE3
NCT05026866 A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04640077 A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT) Status COMPLETED Phase PHASE2
NCT04437511 A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03367403 A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) Status COMPLETED Phase PHASE2